Literature DB >> 20054275

Aggressive surgical resection for hilar cholangiocarcinoma of the left-side predominance: radicality and safety of left-sided hepatectomy.

Hiroaki Shimizu1, Fumio Kimura, Hiroyuki Yoshidome, Masayuki Ohtsuka, Atsushi Kato, Hideyuki Yoshitomi, Katsunori Furukawa, Masaru Miyazaki.   

Abstract

OBJECTIVES: To evaluate the clinicopathologic outcomes in patients with hilar cholangiocarcinoma (HC) after left-sided hepatectomy (L-H). SUMMARY BACKGROUND DATA: L-H is indicated as radical surgery for HC, predominantly involving left hepatic duct. However, several reports have demonstrated that L-H often results in tumor-positive margin and unfavorable prognosis compared with right-sided hepatectomy (R-H).
METHODS: A total of 224 patients with HC underwent surgical resection with curative intent at our institution: L-H for Bismuth-Corlette (B-C) type IIIb tumors in 88 patients (39.3%) including 75 left hemihepatectomies and 13 left trisectionectomies, and R-H mainly for B-C type IIIa and IV tumors in 84 patients (37.5%). In this study, clinicopathologic outcomes and perioperative morbidity and mortality rates after L-H were investigated and compared with those after R-H.
RESULTS: Histologically negative margin (R0) resection was achieved in 56 cases (63.6%) with L-H, similar to the results for R-H (58/84, 69.1%). However, the R0 resection rate in L-H cases with portal vein (PV) resection was lower (11/25, 44.0%), and various types of PV reconstruction were required. Proximal ductal stumps and excisional surface at periductal structures were the most common sites of positive margins. However, when curative resection was achieved, 5-year survival was comparable to that in R-H cases. Furthermore, lower mortality was noted in L-H cases, even with left trisectionectomy. Multivariate analysis indicated curability and hepatic artery resection as independent prognostic factors.
CONCLUSIONS: Since L-H is a safe procedure and represents the only curative resectional option for type IIIb tumor, aggressive surgical resection should be performed even in cases with PV involvement, if R0 resection is possible.

Entities:  

Mesh:

Year:  2010        PMID: 20054275     DOI: 10.1097/SLA.0b013e3181be0085

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  43 in total

1.  Surgical and Radiological Studies on the Length of the Hepatic Ducts.

Authors:  Tomoaki Hirose; Tsuyoshi Igami; Tomoki Ebata; Yukihiro Yokoyama; Gen Sugawara; Takashi Mizuno; Kensaku Mori; Masahiko Ando; Masato Nagino
Journal:  World J Surg       Date:  2015-12       Impact factor: 3.352

2.  Principles of surgical resection in hilar cholangiocarcinoma.

Authors:  Emilio Ramos
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

3.  "Supraportal" right posterior hepatic artery: an anatomic trap in hepatobiliary and transplant surgery.

Authors:  Yuichiro Yoshioka; Tomoki Ebata; Yukihiro Yokoyama; Tsuyoshi Igami; Gen Sugawara; Masato Nagino
Journal:  World J Surg       Date:  2011-06       Impact factor: 3.352

Review 4.  Cholangiocarcinoma--controversies and challenges.

Authors:  Tushar Patel
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-04       Impact factor: 46.802

5.  Narrowing of the remnant portal vein diameter and decreased portal vein angle are risk factors for portal vein thrombosis after perihilar cholangiocarcinoma surgery.

Authors:  Manh-Thau Cao; Ryota Higuchi; Takehisa Yazawa; Shuichiro Uemura; Wataru Izumo; Yutaro Matsunaga; Yasuto Sato; Satoru Morita; Toru Furukawa; Hiroto Egawa; Masakazu Yamamoto
Journal:  Langenbecks Arch Surg       Date:  2021-01-06       Impact factor: 3.445

6.  Transhepatic Direct Approach to the "Limit of the Division of the Hepatic Ducts" Leads to a High R0 Resection Rate in Perihilar Cholangiocarcinoma.

Authors:  Takehiro Noji; Kimitaka Tanaka; Aya Matsui; Yoshitsugu Nakanishi; Toshimichi Asano; Toru Nakamura; Takahiro Tsuchikawa; Keisuke Okamura; Satoshi Hirano
Journal:  J Gastrointest Surg       Date:  2021-01-05       Impact factor: 3.452

7.  Impact of Biliary Drainage on Multidetector-Row Computed Tomography on R0 Resection of Perihilar Cholangiocarcinoma.

Authors:  Isamu Hosokawa; Hiroaki Shimizu; Hideyuki Yoshitomi; Katsunori Furukawa; Tsukasa Takayashiki; Masaru Miyazaki; Masayuki Ohtsuka
Journal:  World J Surg       Date:  2018-11       Impact factor: 3.352

8.  Surgical management trends for cholangiocarcinoma in the USA 1998-2009.

Authors:  Jamie E Anderson; Alan W Hemming; David C Chang; Mark A Talamini; Kristin L Mekeel
Journal:  J Gastrointest Surg       Date:  2012-07-31       Impact factor: 3.452

9.  Tumour size over 3 cm predicts poor short-term outcomes after major liver resection for hilar cholangiocarcinoma. By the HC-AFC-2009 group.

Authors:  Jean Marc Regimbeau; David Fuks; Patrick Pessaux; Philippe Bachellier; Denis Chatelain; Momar Diouf; Artigas Raventos; Georges Mantion; Jean-Francois Gigot; Laurence Chiche; Gerard Pascal; Daniel Azoulay; Alexis Laurent; Christian Letoublon; Emmanuel Boleslawski; Michel Rivoire; Jean-Yves Mabrut; Mustapha Adham; Yves-Patrice Le Treut; Jean-Robert Delpero; Francis Navarro; Ahmet Ayav; Karim Boudjema; Gennaro Nuzzo; Michel Scotte; Olivier Farges
Journal:  HPB (Oxford)       Date:  2014-07-03       Impact factor: 3.647

Review 10.  Multimodal treatment strategies for advanced hilar cholangiocarcinoma.

Authors:  Matthew J Weiss; David Cosgrove; Joseph M Herman; Neda Rastegar; Ihab Kamel; Timothy M Pawlik
Journal:  Langenbecks Arch Surg       Date:  2014-06-25       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.